Johnson & Johnson Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 351 Posts
1 2 3 ... 22
IBB – Challenging 2016, Recovering 2017 And Resurgence In 2018
Article By: Noah Kiedrowski Tuesday, February 6, 2018 3:12 PM EST
The Biotechnology cohort has finally notched a 52-week high and has made up much of the lost ground during the pummeling from both sides of the political isle during the 2016 presidential race.
In this article: AGN, JNJ, NVO, IBB, REGN, GILD, JUNO, ABBV, KITE
Read
J&J Q4 Earnings Top, Pharma Sales Continue To Improve
Article By: Zacks Investment Research Tuesday, January 23, 2018 11:30 AM EST
Johnson & Johnson fourth-quarter 2017 earnings came in at $1.74 per share.
In this article: JNJ Also: GSK, MRK, ABBV
Read
Johnson & Johnson (JNJ): A Dividend King That’s Built To Last
Article By: Simply Safe Dividends Sunday, January 21, 2018 12:00 PM EST
Very few businesses ever come close to growing as large as Johnson & Johnson has become with more than $70 billion in annual revenue.
In this article: JNJ
Read
EC Q4 Earnings Season: Strong Growth, But Weak Quality
Article By: Sheraz Mian Saturday, January 20, 2018 6:24 PM EST
A lot goes into ‘earnings quality’. But as a general rule, it is reasonable to be wary of a big variance between adjusted and GAAP earnings. Going by this simple rule, you have to question the ‘quality’ of Q4 earnings reports.
In this article: TXN, UAL, VZ, PG, NFLX, SBUX, JNJ, INTC, MMM, GE, HON, IBM
Read
Week In Review: Sinocare Eyes $4 Billion Deal For J&J Diabetes Device Business
Article By: ChinaBio® Today Saturday, January 20, 2018 5:34 PM EST
Sinocare, a diabetes company based in Changsha, may bid as much as $4 billion to acquire Johnson & Johnson's diabetes medical device subsidiaries. With falling revenues, some of J&J's diabetes-focused companies are exiting from the US market.
In this article: JNJ, LLY, CELG, BGNE, MRTX, AMRN
Read
Upcoming Consumer Earnings Reports To Watch: JNJ, F, SBUX
Article By: Zacks Investment Research Friday, January 19, 2018 8:30 PM EST
We will see many major reports from noteworthy consumer-facing brands in other industries, so investors will want to be paying attention to all the news. In the coming weeks, we will see reports from the world’s biggest and most relevant companies.
In this article: F, JNJ, SBUX Also: NFLX
Read
Healthcare Investing Ideas Big And Small
Article By: Marc Lichtenfeld Monday, January 15, 2018 9:00 PM EST
With a dire need for growth, many in the industry expect the larger biotech and pharmaceutical companies to open their wallets and acquire smaller companies with novel drugs in development.
In this article: BMY, GSK, JNJ, PFE, AVXL, IMMP, BMRN, FOLD, SGEN, MBOT
Read
Johnson & Johnson Downgraded To Neutral From Overweight At JPMorgan
Article By: The Fly Tuesday, January 2, 2018 8:03 AM EST
JPMorgan analyst Michael Weinstein downgraded Johnson & Johnson to Neutral with an unchanged price target of $150.
In this article: JNJ Also: ABT, BAX
Read
4 Large-Cap Pharma Stocks That Outperformed The S&P This Year
Article By: Zacks Investment Research Sunday, December 31, 2017 2:53 PM EST
Upbeat quarterly results, rise in demand on new product sales, successful innovation and product line expansion, strong clinical study results as well as strong performance of legacy products propelled the large-cap drug sector to new highs in 2017.
In this article: AZN, JNJ, NVO, ABBV Also: RHHBY
Read
Biotech Year One: A Year Of Trials Tribulations And Discovery
Article By: Kieran O'Dea Monday, December 25, 2017 8:24 AM EST
The biotech market is its own beast, derived from the aggregate opinions and knowledge of the mainstream thought. The market has a binary, linear, and simplistic approach to trial results ignoring the context in which each trial is conducted.
In this article: IBB, XBI, XPH, SPY, TEVA, AGN, JNJ, MYL, BMY, BIIB, PFE, MRK, INCY
Read
Why The Dividend Aristocrats Are Good Investments To Generate Long-Term Wealth
Article By: SureDividend Saturday, December 16, 2017 4:15 PM EST
For most, the destination of investing is financial independence. The stock market is an excellent vehicle to accomplish this. More specifically, dividend growth stocks have generated strong returns over the past several decades.
In this article: JNJ, KO, PG
Read
Week In Review: China Life Science Deals Total $550 Million
Article By: ChinaBio® Today Saturday, December 9, 2017 4:13 PM EST
Pfizer (NYSE: PFE​) signed a $226 million agreement for China/Asian rights to Cresemba® (isavuconazole), an antifungal drug and Everest Medicines announced a $224 million partnership with San Diego's Arena Pharma.
In this article: JNJ, GNBT, BYSI, BMY, ARNA, BABA, PFE
Read
Pfizer/Merck KGaA Drug Fails In Study, Teva CEO Announces Changes
Article By: Arpita Dutt Friday, December 1, 2017 8:57 AM EST
While reports about tech giant Amazon meeting generic drugmakers made the rounds, companies like Pfizer and Teva Pharmaceutical Industries Ltd.’s were in the news with the former reporting late-stage data.
In this article: JNJ, PFE, MYL Also: BMY, GSK, TEVA, NVO
Read
Investors Pummel Celgene
Article By: Shock Exchange Friday, October 27, 2017 8:39 PM EST
CELG fell over 15% after Q3 earnings Thursday. Weak guidance, slowing growth from Revlimid and questions over the pipeline spooked investors.
In this article: CELG, VRX, JNJ
Read
An Investor Guide For When The Crash Is In Your Rear Mirror
Article By: The Dividend Guy Thursday, October 26, 2017 1:21 PM EST
Getting rid of weaker positions is not an exact science and you could make mistakes. There is no point of seeing all your stocks as potential losers, but taking off your pinky glasses may not hurt.
In this article: JNJ, MMM, PG
Read
Baby DivHut Dividend Income Portfolio Update Q3 2017
Article By: Keith Park Monday, October 23, 2017 1:00 PM EST
With nine months of the year already behind us, I highlight baby DivHut’s quarterly dividend income/portfolio progress. With the stock market continuing to chug along it was nice to see some impressive gains made in the two-year-old portfolio.
In this article: ABT, CAT, EMR, GIS, ITW, JNJ, MMM, PFE, PG, UL, VFC, YUM, ABBV, YUMC
Read
1 to 16 of 351 Posts
1 2 3 ... 22